Literature DB >> 1503781

Inhibition of differentiation in a murine F9 embryonal carcinoma cell subline by leukemia inhibitory factor (LIF).

G S Brown1, M A Brown, D Hilton, N M Gough, M J Sleigh.   

Abstract

Leukemia inhibitory factor (LIF) is a cytokine previously shown to maintain pluripotent embryonic stem cells in their undifferentiated state. We have examined the effects of LIF in nullipotent embryonal carcinoma cell lines, and have found that LIF blocks differentiation induced by retinoic acid and at low temperature in OTF9 cells. LIF did not block differentiation in a parent F9 cell line. For OTF9 cells, LIF acts early in differentiation, inhibiting the appearance of parietal endoderm-type product cells. However, it acts subsequent to retinoic acid, and at least one early retinoic acid-induced event is unaltered in the presence of LIF. This finding provides both a means of dissecting the cascade of events leading to EC cell differentiation, and a well-characterised target cell type for studying the mechanism of action of LIF.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1503781     DOI: 10.3109/08977199209023936

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  4 in total

1.  Human amniotic epithelial cells maintain mouse spermatogonial stem cells in an undifferentiated state due to high leukemia inhibitor factor (LIF) expression.

Authors:  Te Liu; Lihe Guo; Zhixue Liu; Weiwei Cheng
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-03-18       Impact factor: 2.416

Review 2.  Mechanisms Regulating Stemness and Differentiation in Embryonal Carcinoma Cells.

Authors:  Gregory M Kelly; Mohamed I Gatie
Journal:  Stem Cells Int       Date:  2017-03-08       Impact factor: 5.443

Review 3.  TGFβ Family Signaling Pathways in Pluripotent and Teratocarcinoma Stem Cells' Fate Decisions: Balancing Between Self-Renewal, Differentiation, and Cancer.

Authors:  Olga Gordeeva
Journal:  Cells       Date:  2019-11-23       Impact factor: 6.600

4.  Heterogeneity in the in vitro survival and proliferation of human seminoma cells.

Authors:  R A Olie; L H Looijenga; M C Dekker; F H de Jong; F M van Dissel-Emiliani; D G de Rooij; B van der Holt; J W Oosterhuis
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.